Skip to main content
Glow Lifetech logo

Glow Lifetech — Investor Relations & Filings

Ticker · GLOW ISIN · CA37989H1091 LEI · 5493000039SP09BBAI87 CSE Manufacturing
Open in API
Filings indexed 145 across all filing types
Latest filing 2024-11-30 Regulatory Filings
Country CA Canada
Listing CSE GLOW

About Glow Lifetech

https://glowlifetech.com/

Glow Lifetech is a biotechnology company specializing in ingredient innovation for the nutraceutical and cannabinoid markets. The company supplies cutting-edge, natural active ingredients for functional foods, beverages, supplements, and personal care products. Its core technology is the proprietary MyCell® delivery system, which converts proprietary cannabinoids, vitamins, and botanicals into highly bioavailable, water-soluble liquid formats. This system is engineered to optimize absorption, ensuring dramatically improved bioavailability, faster onset (in as little as 20 minutes), enhanced stability, and a clean, neutral taste profile. Glow offers solutions ranging from foundational water-soluble ingredients and customized blends to fully market-ready products, serving as an innovation partner for companies seeking to launch and scale next-generation natural health products.

Recent filings

Filing Released Lang Actions
52-109FV2 - Certification of interim filings - CFO (E).pdf
Regulatory Filings Classification · 1% confidence The document is a Form 52-109FV2 “Certification of Interim Filings” by the CFO, which is a regulatory certification statement filed alongside interim financial reports. It is not the interim report itself or its MD&A, nor an announcement of publication, but a mandatory regulatory filing. No specific category matches this certificate, so the fallback “Regulatory Filings” (RNS) applies.
2024-11-30 English
52-109FV2 - Certification of interim filings - CEO (E).pdf
Regulatory Filings Classification · 1% confidence The document is Form 52-109FV2, a certification by the CEO of Glow LifeTech Corp. relating to its interim financial report and interim MD&A for the period ended September 30, 2024. It does not present the financial statements or MD&A themselves (so it is not an Interim/Quarterly Report “IR”) nor does it announce the availability of a report (which would be RPA). It is a standalone regulatory compliance filing (certification under National Instrument 52-109), fitting the fallback category for miscellaneous regulatory submissions that do not match other specific report types. Therefore it is classified as a Regulatory Filing (RNS).
2024-11-30 English
Interim MD&A - English.pdf
Management Reports Classification · 1% confidence The document is titled “Management’s Discussion and Analysis of Financial Condition and Results of Operations for the three and nine months ended September 30, 2024, and 2023.” It contains narrative discussion by management of operating results, strategic initiatives, and forward-looking statements. This aligns with the definition of Management Reports (MDA). Thus, the correct filing type is MDA.
2024-11-30 English
Interim financial statements/report – English.pdf
Interim / Quarterly Report Classification · 1% confidence The document is titled 'INTERIM CONSOLIDATED FINANCIAL STATEMENTS' for Glow LifeTech Corp. for the three and nine months ended September 30, 2024. It contains comprehensive financial statements (Statement of Financial Position, Statement of Loss and Comprehensive Loss, Statement of Changes in Shareholders' Equity, and Statement of Cash Flows) along with detailed notes to the financial statements. This meets the definition of an Interim/Quarterly Report (IR) as it provides substantive financial data and analysis for a period shorter than a full fiscal year. 9M 2024
2024-11-30 English
News release - English.pdf
Capital/Financing Update Classification · 1% confidence The document is a press release announcing completion of a non‐brokered private placement of units (capital raise) and share issuance to settle debt, including details on insider participation and early warning reporting. This is a financing update rather than a financial report, earnings release, or other category. Therefore, it should be classified as a Capital/Financing Update.
2024-11-29 English
News release - English.pdf
Regulatory Filings
2024-10-22 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.